Sunshine Biopharma jumps on Q1 sales boost from generic unit Nora Pharma
** U.S.-listed shares of Canada's Sunshine Biopharma Inc.
SBFM.O up about 78% at 95 cents
** Q1 sales jump to $4.9 mln vs. $122,645 a year earlier,
led by the sales of prescription drugs from generic unit Nora
Pharma Inc.
** Sunshine Biopharma acquired Nora Pharma in October for
about $21.9 mln
** Net loss widened to $1.7 mln from $1.2 mln a year eariler
** SBFM up about 61% YTD
(Reporting by Vaibhav Sadhamta)
((Vaibhav.Sadhamta@thomsonreuters.com;))